NEOPLASMA
Article List
Volume 52, 2005, No. 5
ISSN 0028-2685 (print)
ISSN 1338-4317 (online)
Content:
- KODA, M. - SULKOWSKA, M. - KANCZUGA-KODA, L. - GOLASZEWSKA, J. - KISIELEWSKI, W. - BALTAZIAK, M. - WINCEWICZ, A. - SULKOWSKI, S.: Expression of the Insulin Receptor Substrate 1 in primary tumors and lymph node metastases in breast cancer: correlations with Bcl-xL and Bax proteins. (p. 361)
- HABALOVÁ, V. - ŠALAGOVIČ, J. - KALINA, I. - ŠTUBŇA, J.: A pilot study testing the genetic polymorphism of N-acetyltransferase 2 as a risk factor in lung cancer. (p. 364)
- CHEN, J. - LEE, Y. - CHEN, T. - WANG, K. - DANG, C. - CHANG, S. - LIU, H. - YANG, Y.: MHC class I chain-related gene A (MICA) polymorphism and the different histological types of cervical cancer. (p. 369)
- GIEFING, M. - RYDZANICZ, M. - SZUKALA, K. - WOZNIAK, A. - WIERZBICKA, M. - SZYFTER, K. - KUJAWSKI, M.: Second primary tumors (SPT) of head and neck. Distinguishing of "true" SPT from micrometastasis by LOH analysis of selected chromosome regions. (p. 374)
- VRANOVÁ, V. - KATINA, S. - KIRSCHNEROVÁ, G. - MISTRÍK, M. - LAKOTA, J. - HORÁKOVÁ, J. - TÓTHOVÁ, A.: A significance of additional chromosomal aberrations and other variables on post transplantation outcome of patients with CML. (p. 381)
- KOTYZA, J. - PEŠEK, M. - BEDNÁŘOVÁ, V. - TEŘL, M. - WERLE, B.: Pleural fluids associated with metastatic lung tumors are rich in progelatinase B/proMMP-9. (p. 388)
- FELTL, D. - ZÁVADOVÁ, E. - PÁLA, M. - HOZÁK, P.: Posttreatment plasma transforming growth factor beta 1 (TGF-beta1) level predicts for late morbidity in patients with advanced head and neck cancer. (p. 393)
- LEMEŽ, P. - URBÁNEK, V.: Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients. (p. 398)
- JUNGHANSS, C. - WAAK, M. - KNOPP, A. - KLEINE, H. - KUNDT, G. - LEITHÄUSER, M. - HILGENDORF, I. - WOLFF, D. - CASPER, J. - FREUND, M.: Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression. (p. 402)
- DOUBEK, M. - PALASEK, I. - BRYCHTOVA, Y. - BUCHTOVA, I. - MAYER, J.: Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy. (p. 411)
- BEDRNICEK, J. - VICHA, A. - JAROSOVA, M. - HOLZEROVA, M. - CINATL, JR., J. - MICHAELIS, M. - CINATL, J. - ECKSCHLAGER, T.: Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization. (p. 415)
- OSHIMA, C. - IRIYA, K. - FORONES, N.: Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer. (p. 420)
- VASILEV, N. - MOMEKOV, G. - ZAHARIEVA, M. - KONSTANTINOV, S. - BREMNER, P. - HEINRICH, M. - IONKOVA, I.: Cytotoxic activity of a podophyllotoxin-like lignan from Linum tauricum Willd. (p. 425)
- HORÁČEK, J. - PUDIL, R. - TICHÝ, M. - JEBAVÝ, L. - ŠTRASOVÁ, A. - PRAUS, R. - ŽÁK, P. - MALÝ, J.: The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia. (p. 430)